Combining genetic and biochemical approaches to identify functional molecular contact points

被引:4
作者
Badtke, Matthew P.
Cao, Feng
Tavis, John E.
机构
[1] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA
[2] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA
[3] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO 63104 USA
关键词
hepatitis B virus; duck; protein interaction mapping;
D O I
10.1251/bpo121
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Protein-protein interactions are required for many viral and cellular functions and are potential targets for novel therapies. Here we detail a series of genetic and biochemical techniques used in combination to find an essential molecular contact point on the duck hepatitis B virus polymerase. These techniques include differential immunoprecipitation, mutagenesis and peptide competition. The strength of these techniques is their ability to identify contact points on intact proteins or protein complexes employing functional assays. This approach can be used to aid identification of putative binding sites on proteins and protein complexes which are resistant to characterization by other methods.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 28 条
[1]
Protein-protein interactions and cancer: small molecules going in for the kill [J].
Arkin, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (03) :317-324
[2]
Efficient hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein [J].
Beck, J ;
Nassal, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36128-36138
[3]
Identification of an essential molecular contact point on the duck hepatitis B virus reverse transcriptase [J].
Cao, F ;
Badtke, MP ;
Metzger, LM ;
Yao, E ;
Adeyemo, B ;
Gong, YH ;
Tavis, JE .
JOURNAL OF VIROLOGY, 2005, 79 (16) :10164-10170
[4]
SPECIFIC-INHIBITION OF HERPESVIRUS RIBONUCLEOTIDE REDUCTASE BY A NONAPEPTIDE DERIVED FROM THE CARBOXY TERMINUS OF SUBUNIT-2 [J].
COHEN, EA ;
GAUDREAU, P ;
BRAZEAU, P ;
LANGELIER, Y .
NATURE, 1986, 321 (6068) :441-443
[5]
CONSTRUCTION AND CHARACTERIZATION OF A SINGLE-CHAIN CATALYTIC ANTIBODY [J].
GIBBS, RA ;
POSNER, BA ;
FILPULA, DR ;
DODD, SW ;
FINKELMAN, MAJ ;
LEE, TK ;
WROBLE, M ;
WHITLOW, M ;
BENKOVIC, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :4001-4004
[6]
Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction [J].
Ho, TY ;
Wu, SL ;
Chen, JC ;
Wei, YC ;
Cheng, SE ;
Chang, YH ;
Liu, HJ ;
Hsiang, CY .
ANTIVIRAL RESEARCH, 2006, 69 (02) :70-76
[7]
In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins [J].
Hu, JM ;
Toft, D ;
Anselmo, D ;
Wang, XT .
JOURNAL OF VIROLOGY, 2002, 76 (01) :269-279
[8]
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo [J].
Kuo, CC ;
Hsieh, HP ;
Pan, WY ;
Chen, CP ;
Lion, JP ;
Lee, SJ ;
Chang, YL ;
Chen, LT ;
Chen, CT ;
Chang, JY .
CANCER RESEARCH, 2004, 64 (13) :4621-4628
[9]
Medical progress - Hepatitis B virus infection [J].
Lee, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24) :1733-1745
[10]
Disruption of protein-protein interactions:: Towards new targets for chemotherapy [J].
Loregian, A ;
Palú, G .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 204 (03) :750-762